Rock Springs Capital Management LP Cerevel Therapeutics Holdings, Inc. Transaction History

Rock Springs Capital Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$40.88 - $43.27 $86.9 Million - $92 Million	-2,126,299 Reduced 79.51%	547,946 $23.2 Million
Q4 2023 Feb 14, 2024	BUY	$20.27 - $42.44 $2.94 Million - $6.16 Million	145,129 Added 5.74%	2,674,245 $113 Million
Q3 2023 Nov 14, 2023	BUY	$20.26 - $31.91 $307,952 - $485,032	15,200 Added 0.6%	2,529,116 $55.2 Million
Q1 2023 May 15, 2023	BUY	$22.82 - $35.32 $170,054 - $263,204	7,452 Added 0.3%	2,513,916 $61.3 Million
Q4 2022 Feb 14, 2023	BUY	$25.35 - $31.96 $185,460 - $233,819	7,316 Added 0.29%	2,506,464 $79.1 Million
Q3 2022 Nov 14, 2022	BUY	$25.5 - $41.42 $18.7 Million - $30.3 Million	732,007 Added 41.42%	2,499,148 $70.6 Million
Q2 2022 Aug 15, 2022	BUY	$20.62 - $37.15 $903,156 - $1.63 Million	43,800 Added 2.54%	1,767,141 $46.7 Million
Q1 2022 May 16, 2022	BUY	$23.5 - $35.38 $1.76 Million - $2.65 Million	74,906 Added 4.54%	1,723,341 $60.3 Million
Q4 2021 Feb 14, 2022	BUY	$29.21 - $44.64 $1.4 Million - $2.14 Million	47,846 Added 2.99%	1,648,435 $53.4 Million
Q3 2021 Nov 15, 2021	BUY	$21.26 - $38.85 $12.4 Million - $22.7 Million	583,644 Added 57.39%	1,600,589 $47.2 Million
Q2 2021 Aug 16, 2021	BUY	$12.56 - $29.69 $148,773 - $351,678	11,845 Added 1.18%	1,016,945 $26.1 Million
Q1 2021 May 17, 2021	BUY	$12.37 - $17.74 $75,457 - $108,213	6,100 Added 0.61%	1,005,100 $13.8 Million
Q4 2020 Feb 16, 2021	BUY	$9.82 - $18.27 $9.81 Million - $18.3 Million	999,000 New	999,000 $16.6 Million

242

154M

2.19M

3.87M

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.